Pricing Log in Create free account

Alpha Cognition Inc. (ACOG) vs Entrada Therapeutics, Inc. (TRDA)

Alpha Cognition Inc. and Entrada Therapeutics, Inc. are both Biotechnology companies. Alpha Cognition Inc. and Entrada Therapeutics, Inc. are of similar size ($191.5M and $180.5M). Alpha Cognition Inc. has the higher net margin (−137.7% vs −4,058.0%) and the higher return on invested capital (−144.7% vs −2,009.0%). Across the 15 metrics below, Alpha Cognition Inc. leads on 11 and Entrada Therapeutics, Inc. on 4.

Valuation

Metric ACOG TRDA Biotechnology median
P/E n/m n/m 10.60
P/S 11.83 52.10 9.40
P/B 3.41 1.04 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 9.18 3.57 9.02
Earnings yield (11.58%) (78.53%) (32.88%)
Free cash flow yield (20.54%) (65.80%) (23.13%)

Profitability

Metric ACOG TRDA Biotechnology median
Gross margin 90.37% 100.00% 68.51%
Operating margin (174.70%) (4,303.82%) 0.00%
Net margin (137.69%) (4,057.98%) 0.00%
Free cash flow margin (242.99%) (3,428.06%) 0.00%
Return on equity (49.53%) (59.88%) (51.96%)
Return on assets (38.33%) (47.48%) (46.06%)
Return on invested capital (144.65%) (2,008.96%) 0.00%

Growth

Metric ACOG TRDA Biotechnology median
Revenue growth (TTM) — (93.54%) 6.76%
EPS growth (last fiscal year) 42.08% (306.55%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACOG TRDA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.03 7.85 4.97
Net debt to EBITDA 2.92 1.88 1.01

Dividend

Metric ACOG TRDA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACOG TRDA Biotechnology median
Market cap 180.54m 191.45m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack